ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.831,74
-0,22%
S&P 500
5.243,16
-0,65%
US Dollar vs BRL
5,2344
-0,23%
Bitcoin
68.992,01
1,84%
Brent Oil
78,31
-3,09%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Austrália
  5. ASX
  6. Aeon Metals Limited (AMLN)

  7. Aeon Metals Limited (AMLN) Notícias

AMLN

Aeon Metals (AMLN)

Aeon Metals Limited
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:ASX:AMLN
DataHoraFonteTítuloCódigoCompanhia
29/10/200910:34Dow Jones NewsUPDATE: Roche's New Diabetes Drug Works Better Than ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
29/10/200907:02Dow Jones NewsRoche: New Diabetes Drug Works Better Than Byetta - StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200919:21Dow Jones News2ND UPDATE:Galleon Holdings Include OSI Pharma,Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200918:17Dow Jones NewsUPDATE: Galleon Holdings Include OSI Pharma, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
19/10/200918:05Dow Jones NewsGalleon Holdings Include OSI Pharmaceuticals, Huron ConsultingNASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/09/200907:16Dow Jones NewsNovo Nordisk's Diabetes Drug Victoza Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/08/200909:28Dow Jones NewsNovo Nordisk CEO: Positive Victoza Reception In EuropeNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/07/200918:20Dow Jones NewsAmylin 2Q Loss Narrows On Cost-Cutting; Byetta Sales SlipNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200908:01Dow Jones NewsUPDATE: Novo Nordisk Diabetes Drug Victoza Gets EU ApprovalNASDAQ:AMLNAmylin Pharmaceuticals Inc.
03/07/200907:06Dow Jones NewsNovo Nordisk's Victoza To Reach Market In A Few Weeks - CSONASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200907:30Dow Jones NewsDoctors Say New Diabetes Drugs Hold Great PromiseNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200904:13Dow Jones NewsCORRECT: Study: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200904:12Dow Jones NewsNovo Nordisk Diabetes Drug Liraglutide Successful In StudyNASDAQ:AMLNAmylin Pharmaceuticals Inc.
09/06/200904:12Dow Jones NewsStudy: Novo Nordisk's Diabetes Drug Beats Lilly's ByettaNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200921:00Dow Jones NewsUPDATE: Weekly Diabetes Drug Byetta Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
06/06/200916:22Dow Jones NewsStudy Shows Weekly Byetta Diabetes Drug Outdoes CompetitorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200914:59Dow Jones NewsUPDATE: Amylin: 2 Dissidents To Replace Chairman, Lead DirNASDAQ:AMLNAmylin Pharmaceuticals Inc.
02/06/200914:36Dow Jones NewsAmylin: 2 Dissidents To Replace Chairman, Lead DirectorNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200917:37Dow Jones NewsUPDATE: Amylin: Dissidents Likely Got Up To Two Board SeatsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
27/05/200917:05Dow Jones NewsEastbourne Claims Success In Electing Directors To Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
21/05/200916:02Dow Jones NewsHedge Fund Mgr Schoenfeld Backs Icahn/Eastbourne Amylin SlateNASDAQ:AMLNAmylin Pharmaceuticals Inc.
18/05/200909:17Dow Jones NewsMore Proxy Advisers Back Dissidents' Amylin Board NomineesNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200919:24Dow Jones NewsUPDATE: Risk Metrics Backs Three Dissident Amylin DirectorsNASDAQ:AMLNAmylin Pharmaceuticals Inc.
15/05/200918:53Dow Jones NewsRisk Metrics Backs Three Dissident Directors For Amylin BoardNASDAQ:AMLNAmylin Pharmaceuticals Inc.
14/05/200912:13Dow Jones NewsUPDATE: Icahn Fires Back At Amylin Over Latest LetterNASDAQ:AMLNAmylin Pharmaceuticals Inc.
04/05/200918:29Dow Jones NewsAmylin To Trim Sales Team by 35%, Sees $45 Million Savings In '10NASDAQ:AMLNAmylin Pharmaceuticals Inc.
30/04/200915:55Dow Jones NewsDEALWATCH: Lilly Can't Afford To Double Down With AmylinNASDAQ:AMLNAmylin Pharmaceuticals Inc.
28/04/200917:03Dow Jones NewsAmylin Proxy Battle Adds To Debate Over What Makes A 'Group'NASDAQ:AMLNAmylin Pharmaceuticals Inc.
24/04/200906:47Dow Jones NewsUPDATE: Novo Nordisk Has Big Hopes For EU Victoza LaunchNASDAQ:AMLNAmylin Pharmaceuticals Inc.
20/04/200916:01Dow Jones NewsUPDATE: US Drug Stocks Flee Into Negative TerritoryNASDAQ:AMLNAmylin Pharmaceuticals Inc.
 Apresentando as notícias mais relevantes sobre:ASX:AMLN

Seu Histórico Recente

BIT
Q00232
Leonteq Securities
NYSE
BVN
Compania De Minas Buenav...
EU
P745S
P745S
USOTC
GXCCF
Global X Funds China Cle... (CE)
COIN
ADAGBP
Cardano
NASDAQ
MVST
Microvast
BIT
P1T5C5
BNP Paribas Issuance
AMEX
SLYG
SPDR S&P 600 Small Cap G...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados